Template:Otitis Externa Antibiotics: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
#'''[[Floxin otic]]''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref> | #'''[[Floxin otic]]''': 5 drops in affected ear BID x 7 days<ref name="CPGENT2014">Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 [http://www.aepap.org/sites/default/files/otitis_externa_guia2014-rosenfeld-161-8_0.pdf PDF]</ref> | ||
#*Safe with perforations | #*Safe with perforations | ||
#'''[[Cipro HC otic]]''': 3 drops in affected ear BID x 7 days | #'''[[Ciprofloxacin|Cipro HC otic]]''': 3 drops in affected ear BID x 7 days | ||
#*Contains hydrocortisone to promote faster healing | #*Contains hydrocortisone to promote faster healing | ||
#*Not safe with perforation | #*Not safe with perforation | ||
#'''[[CiproDex]]''': 4 drops in affected ear BID x 7 days | #'''[[Ciprofloxacin|CiproDex]]''': 4 drops in affected ear BID x 7 days | ||
#*Similar to Cipro HC but contains [[dexamethasone]] | #*Similar to Cipro HC but contains [[dexamethasone]] | ||
#'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone) | #'''[[Cortisporin otic]]''' (neomycin/polymixin B/hydrocortisone) | ||
Revision as of 22:22, 25 August 2019
- Floxin otic: 5 drops in affected ear BID x 7 days[1]
- Safe with perforations
- Cipro HC otic: 3 drops in affected ear BID x 7 days
- Contains hydrocortisone to promote faster healing
- Not safe with perforation
- CiproDex: 4 drops in affected ear BID x 7 days
- Similar to Cipro HC but contains dexamethasone
- Cortisporin otic (neomycin/polymixin B/hydrocortisone)
- 4 drops in ear TID-QID x 7days
- Use suspension (NOT solution) if possiblity of perforation
- Animal studies suggest possible toxicity from the neomycin although rigorous data is lacking[2]
- ↑ Clinical Practice Guideline: Acute Otitis Externa Executive Summary. Otolaryngology -- Head and Neck Surgery 2014 150: 161 DOI: 10.1177/0194599813517659 PDF
- ↑ Wright, C. et al. Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon. Am J Otol. 1987 Nov;8(6):495-9.